Table 2.

Demographic, Clinical, and Pathologic Characteristics of the 12 Enrolled Patients

Patient/Tumor Characteristic	No. (%)
Age, y
Median	68
Range	43–72
Sex
Male	7
Female	5
Tumor histology, no./total no. (%)
Classic papillary	2/12 (17)
Tall-cell variant papillary	5/12 (42)
Columnar cell papillary	2/12 (17)
Poorly differentiated carcinoma	3/12 (25)
Tumor genotype, no./total no. (%)
BRAF V600E	12/12 (100)
Prior radioiodine treatments per patient, no.
Median	1
Range	1–3
Other treatments for thyroid cancer, no. of patients/total no. (%)
External-beam radiation therapy	5/12 (42)
Doxorubicin (concurrently with radiation therapy)	2/12 (17)
Vascular endothelial growth factor receptor–targeted TKI	1/12 (8)